To gain insight into the commercial changes occurring in the oncology industry, Campbell Alliance initiated the Oncology National Commercial (ONC) study where 75 key industry experts, physicians, payers, and opinion leaders were surveyed.
The study revealed an alarming pattern that told us that the oncology space is transforming in such a way that never-before-seen competition is now built into the “DNA” of the business of oncology, and few companies are prepared to operate in the face of this intense competition.
Download the article to see the 10 Trends found in the ONC survey
What are your thoughts on this topic? Join the discussion in the Optimizing Oncology Clinical Research group on LinkedIn.